Cannabis stocks gave back some ground on the last day of the trading week, but overall it was a quiet day for the sector.
The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, dropped 0.9% to 102 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 1.3% t0 C$8.71, while the OTCQX Cannabis index slipped 0.8% to 413.8 points.
Buds
XPhyto Therapeutics Corp (CSE:XPHY) (OTCMKTS:XPHYF) ticked higher as the company kicks off a European deal with the Technical University of Munich and the School of Life Sciences Weihenstephan.
The science-based cannabis company, which operates a German subsidiary, gained 3.3% on the CSE to C$2.19.
Elsewhere, cannabis consulting firm MariMed Inc (OTCMKTS:MRMD) saw shares rise 6.8% to US$0.33.
Duds
HEXO Corp (TSE:HEXO) (NYSE:HEXO) shares dipped after the company was downgraded to 'Underperform' with a $1 price target by analysts at Jefferies, according to Seeking Alpha.
The Quebec cannabis producer saw its stock fall 1% to C41.89 on Bay Street and 0.7% to US$1.43 on Wall Street.
Meanwhile, UK biopharmaceutical cannabis company GW Pharmaceuticals plc (NASDAQ:GWPH) declined 3.9% to US$124.69.
Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com
Follow him on Twitter @andrew_kessel